Aurobindo Pharma shares react after USFDA issues observation

USFDA issued one observation after inspecting an API manufacturing facility of Aurobindo Pharma’s wholly owned subsidiary Apitoria Pharma in Gaddapotharam, Telangana. The inspection ran Sept. 7–Sept. 15, and TradingView News says shares will remain in focus on Sept. 16.